Lam Research (NASDAQ:LRCX) Trading 4.4% Higher – Here’s What Happened

Shares of Lam Research Corporation (NASDAQ:LRCX) shot up 4.4% during trading on Monday . The stock traded as high as $167.15 and last traded at $166.37. 10,020,010 shares changed hands during trading, a decline of 15% from the average session volume of 11,854,602 shares. The stock had previously closed at $159.35.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Mizuho upped their price objective on shares of Lam Research from $162.00 to $170.00 and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Evercore ISI boosted their price target on shares of Lam Research from $115.00 to $170.00 and gave the company an “outperform” rating in a report on Thursday, October 23rd. Zacks Research raised shares of Lam Research from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 20th. Raymond James Financial lifted their price objective on Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a research report on Thursday, July 31st. Finally, Needham & Company LLC lifted their price target on Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $148.54.

Lam Research Stock Performance

The firm has a fifty day simple moving average of $134.94 and a 200 day simple moving average of $106.90. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The company has a market cap of $208.97 billion, a price-to-earnings ratio of 36.65, a P/E/G ratio of 1.68 and a beta of 1.87.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. Lam Research’s revenue was up 27.7% compared to the same quarter last year. During the same period last year, the business posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, sell-side analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be paid a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.6%. Lam Research’s payout ratio is presently 22.91%.

Insider Activity at Lam Research

In other news, Director Bethany Mayer sold 1,298 shares of the stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 62,528 shares of company stock worth $8,880,448 in the last 90 days. 0.31% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in shares of Lam Research by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 130,974,214 shares of the semiconductor company’s stock worth $17,537,447,000 after acquiring an additional 364,949 shares during the period. State Street Corp lifted its position in Lam Research by 1.1% in the second quarter. State Street Corp now owns 59,551,547 shares of the semiconductor company’s stock worth $5,810,172,000 after purchasing an additional 629,666 shares during the period. JPMorgan Chase & Co. lifted its position in Lam Research by 14.4% in the second quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock worth $3,954,188,000 after purchasing an additional 5,102,589 shares during the period. Geode Capital Management LLC boosted its stake in Lam Research by 3.5% during the second quarter. Geode Capital Management LLC now owns 33,802,736 shares of the semiconductor company’s stock worth $3,280,484,000 after buying an additional 1,135,405 shares in the last quarter. Finally, Norges Bank bought a new stake in Lam Research in the 2nd quarter valued at $1,894,585,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.